Interleukin-1β and tumor necrosis factor-α induce expression of α1- antichymotrypsin in human astrocytoma cells by activation of nuclear factor- κB

Journal of Neurochemistry

Volumn 67, Issue 5, 1996, Pages 2039-2044

  Lieb, Klaus ^a   Fiebich, Bernd L ^a   Schaller, Helen ^a   Berger, Mathias ^a   Bauer, Joachim ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Alzheimer's disease; Interleukin 1; Nuclear factor B; Regulation of gene expression; Tumor necrosis factor ; 1 Antichymotrypsin

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTOMA CELL; CONTROLLED STUDY; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029823018     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67052039.x     Document Type: Article

References (41)

1. Abraham C. R., Selkoe D. J., and Potter H. (1988) Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52, 487-501.
2. Abraham C. R., Shirahama T., and Potter H. (1990) Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin. Neurobiol. Aging 11, 123-129.
3. Altstiel L. D., Lawlor B., Mohs R., Schmeidler J., Dalton A., Mehta P., and Davis K. (1995) Elevated alpha 1-antichymotrypsin serum levels in a subset of nondemented first-degree relatives of Alzheimer's disease patients. Dementia 6, 17-20.
4. Baeuerle P. A. and Baltimore D. (1988) IκB: a specific inhibitor of the NF-κB transcription factor. Science 242, 540-546.
5. Baeuerle P. A. and Henkel T. (1994) Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-179.
6. Bauer J., Strauss S., Schreiter-Gasser U., Ganter U., Schlegel P., Witt I., Volk B., and Berger M. (1991a) Interleukin-6 and alpha2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285, 111-114.
7. Bauer J., Strauss S., Volk B., and Berger M. (1991b) Interleukin-6-mediated events in Alzheimer's disease pathology. Immunol. Today 12, 422.
8. Bauer J., Ganter U., Strauss S., Stadtmueller G., Frommberger U., Bauer H., Volk B., and Berger M. (1992) The participation of interleukin-6 in the pathogenesis of Alzheimer's disease. Res. Immunol. 143, 650-657.
9. Baumann H. and Gauldie J. (1994) The acute phase response. Immunol. Today 15, 74-80.
10. Blum-Degen D., Müller T., Kuhn W., Gerlach M., Przuntek H., and Riederer P. (1995) Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 202, 17-20.
11. 1antichymotrypsin in Down's syndrome and Alzheimer's disease. Ann. Neurol. 32, 193-197.
12. Das S. and Potter H. (1995) Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron 14, 447-456.
13. Delamarche C., Berger F., Gallard L., and Pouplard-Barthelaix A. (1991) Aging and Alzheimer's disease: protease inhibitors in cerebrospinal fluid. Neurobiol. Aging 12, 71-74.
14. Eriksson S., Janciauskiene S., and Lannfelt L. (1995) Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation. Proc. Natl. Acad. Sci. USA 92, 2313-2317.
15. Griffin W. S. T., Stanley L. C., Ling C., White L., MacLeod V., Perrot L. J., White C. L., and Araoz C. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 86, 7611-7615.
16. Griffin W. S. T., Sheng J. G., Roberts G. W., and Mrak R. E. (1995) Inlerleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J. Neuropathol. Exp. Neurol 54, 276-281.
17. Harigaya Y., Shoji M., Nakamura T., Matsubara E., Hosoda K., and Hirai S. (1995) Alpha 1-antichymotrypsin level in cerebrospinal fluid is closely associated with late onset Alzheimer's disease. J. Int. Med. Res. 34, 481-484.
18. Hinds T. R., Kukull W. A., Van Belle G., Schellenberg G. D., Villacres E. C., and Larson E. B. (1994) Relationship between serum alpha 1-antichymotrypsin and Alzheimer's disease. Neurobiol. Aging 15, 21-27.
19. Huell M., Strauss S., Volk B., Berger M., and Bauer J. (1995) Interleukin-6 is present in early stages of plaque formation and is restricted to brains of Alzheimer's disease patients. Acta Neuropathol. 89, 544-551.
20. Kalaria R. N. and Perry G. (1993) Amyloid P component and other acute-phase proteins associated with cerebellar A beta-deposits in Alzheimer's disease. Brain Res. 631, 151-155.
21. Kamboh M. I., Sanghera D. K., Ferrell R. E., and DeKosky S. T. (1995) APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nat. Genet. 10, 486-488.
22. Kuiper M. A., van Kamp G. J., Bergmans P. L., Scheltens P., and Wolters E. C. (1993) Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease. J. Neural Transm. Park. Dis. Dement. Sect. 6, 145-149.
23. Licastro F., Morini M. C., Polazzi E., and Davis L. J. (1995) Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response. J. Neuroimmunol. 57, 71-75.
24. Lieb K., Kaltschmidt C., Kaltschmidt B., Baeuerle P. A., Berger M., Bauer J., and Fiebich B. L. (1996) Interleukin-1β uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor a genes in the human astrocytoma cell line U373 MG. J. Neurochem. 66, 1496-1503.
25. Ma J., Yee A., Brewer H. B. Jr., Das S., and Potter H. (1994) Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372, 92-94.
26. 1,-antichymotrypsin expression in the human astrocytoma cell line U373 MG. Neuroreport 6, 2283-2286.
27. Matsubara E., Hirai S., Amari M., Shoji M., Yamaguchi H., Okamoto K., Ishiguro K., Harigaya Y., and Wakabayashi K. (1990) Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Ann. Neurol. 28, 561-567.
28. 2 and antioxidants have opposite effects on activation of NF- kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12, 2005-2015.
29. Norris J. G., Tang L. P., Sparacio S. M., and Benveniste E. N. (1994) Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha. J. Immunol. 152, 841-850.
30. Pastemack J. M., Abraham C. R., Van Dyke B. J., Potter H., and Younkin S. G. (1989) Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA. Am. J. Pathol. 135, 827-834.
31. Picken M. M., Larrondo-Lillo M., Coria F., Gallo G. R., Shelanski M. L., and Frangione B. (1990) Distribution of the protease inhibitor alpha 1-antichymotrypsin in cerebral and systemic amyloid. J. Neuropathol. Exp. Neurol. 49, 41-48.
32. Pirttila T., Mehta P. D., Frey H., and Wisniewski H. M. (1994) Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease. Neurobiol. Aging 15, 313-317.
33. Rossi B. (1993) IL-1 transduction signals. Eur. Cytokine Netw. 4, 181-187.
34. Rozetnuller J. M., Stam F. C., and Eikelenboom P. (1990) Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease. Neurosci. Lett. 119, 75-78.
35. Schöbitz B., Ron de Kloet E., and Holsboer F. (1994) Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog. Neurobiol. 44, 397-432.
36. Schreck R., Albermann K., and Baeuerle P. A. (1992) Nuclear factor kappa B: an oxidative stress-response transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 17, 221-237.
37. Shoji M., Hirai S., Yamaguchi H., Harigaya Y., Ishiguro K., and Matsubara E. (1991) Alpha 1-antichymotrypsin is present in diffuse senile plaques. A comparative study of beta-protein and alpha 1-antichymotrypsin immunostaining in the Alzheimer brain. Am. J. Pathol. 138, 247-257.
38. Sparacio S. M., Zhang Y., Vilcek J., and Benveniste E. N. (1992) Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-kappa B-like nuclear protein. J. Neuroimmunol. 39, 231-242.
39. Strauss S., Bauer J., Ganter U., Jonas U., Berger M., and Volk B. (1992) Detection of interleukin-6 and alpha2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab. Invest. 66, 223-230.
40. Thome J., Baumer A., Kornhuber J., Rösler R., and Riederer P. (1995) Alpha-1-antichymotrypsin β1-allele polymorphism, apolipoprotein-E tri allele polymorphism and genetic risk of Alzheimer's syndrome. J. Neural Transm. Park. Dis. Dement. Sect. 10, 207-212.
41. Vandenabeele P. and Fiers W. (1991) Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated "acute phase response" in the brain? Immunol. Today 12, 217-219.